Close
Back to CNST Stock Lookup
Pages: 1 2 3 »» Last Page

Constellation Pharmaceuticals (CNST) – Press Releases

Jul 15, 2021 02:20 AM MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
Jul 1, 2021 10:45 AM MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals
Jun 23, 2021 12:01 PM SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, FMBI, SLCT, and CNST Shareholders About Its Ongoing Investigations
Jun 16, 2021 12:20 PM SHAREHOLDER ALERT: WeissLaw LLP Reminds FMBI, SLCT, CNST, and DISCA Shareholders About Its Ongoing Investigations
Jun 11, 2021 09:00 AM Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
Jun 11, 2021 09:00 AM Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
Jun 9, 2021 01:04 PM SHAREHOLDER ALERT: WeissLaw LLP Reminds COHR, FMBI, SLCT, and CNST Shareholders About Its Ongoing Investigations
Jun 4, 2021 09:00 AM Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting
Jun 4, 2021 09:00 AM Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting
Jun 3, 2021 02:27 PM CONSTELLATION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CNST and Encourages Investors to Contact the Firm
Jun 2, 2021 07:45 AM MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma
Jun 2, 2021 07:40 AM Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
Jun 2, 2021 07:40 AM Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
Jun 2, 2021 07:25 AM MorphoSys to Acquire Constellation Pharmaceuticals
May 31, 2021 09:00 AM Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 31, 2021 09:00 AM Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 10, 2021 07:00 AM Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update
Apr 27, 2021 11:30 AM Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results
Feb 24, 2021 07:00 AM Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
Feb 19, 2021 04:00 PM Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
Feb 19, 2021 04:00 PM Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
Feb 18, 2021 10:00 AM Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
Jan 7, 2021 09:30 AM Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer
Jan 7, 2021 09:30 AM Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer
Jan 6, 2021 10:00 AM Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 6, 2021 10:00 AM Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Dec 6, 2020 08:00 AM Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH Meeting
Dec 6, 2020 08:00 AM Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH Meeting
Nov 23, 2020 01:00 PM Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 Presented at ASH Meeting
Nov 23, 2020 01:00 PM Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 Presented at ASH Meeting
Oct 29, 2020 07:00 AM Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results
Oct 19, 2020 02:00 PM Constellation Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2020 Results
Sep 9, 2020 03:00 PM Constellation Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
Sep 9, 2020 03:00 PM Constellation Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
Aug 5, 2020 07:00 AM Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update
Aug 5, 2020 07:00 AM Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update
Jun 16, 2020 08:27 PM Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jun 16, 2020 08:27 PM Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jun 15, 2020 04:01 PM Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jun 15, 2020 04:01 PM Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jun 12, 2020 02:30 AM Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise
Jun 12, 2020 02:30 AM Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise
Jun 10, 2020 11:30 AM Constellation Pharmaceuticals to Participate in Investor Conference
Jun 10, 2020 11:30 AM Constellation Pharmaceuticals to Participate in Investor Conference
Jun 8, 2020 08:00 AM Constellation Pharmaceuticals Announces Appointment of Dr. Jeffrey Humphrey as Chief Medical Officer
May 29, 2020 09:00 AM Constellation Pharmaceuticals to Participate in Investor Conference
May 29, 2020 09:00 AM Constellation Pharmaceuticals to Participate in Investor Conference
May 28, 2020 12:00 PM Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610
May 28, 2020 12:00 PM Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610
May 14, 2020 08:00 AM Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts
Pages: 1 2 3 »» Last Page

Back to CNST Stock Lookup